This report addresses particular accounting issues the pharmaceuticals and life sciences sector faces when using the US Generally Accepted Accounting Principles (US GAAP). The aim is to highlight the industry-specific factors which need to be considered, and to provide an opinion on the most pertinent accounting solutions for commercial situations under US GAAP.
Every company deals with accounting issues that should reflect the facts and circumstances of their particular situation. The 82 solutions in this publication cover general situations and provide a framework for determining the appropriate accounting answer. However, individual fact patterns may give rise to a different answer.
Publications Search Page
